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Abstract
Kinetic studies on the stability of two non-steroids anti-inflammatory drugs (NSAIDs), ibuprofen 
and mefenamic acid in purified water and activated sludge indicated that both were resistance to 
degradation during 30 days. The efficiency of sequential advanced membrane technology 
wastewater treatment plant towards removal of both drugs from wastewater was investigated. 
The sequential system included activated sludge, ultrafiltration (hollow fiber membranes with 
100 kDa cutoff, and spiral wound membranes (20 kDa cutoff), activated carbon column and 
reverse osmosis.  The overall performance of the integrated plant showed complete removal of 
ibuprofen and mefenamic acid from spiked wastewater samples. Activated carbon column was
the most effective component in removing these non-steroidal anti-inflammatory drugs with 
removal efficiency 98.8% for both ibuprofen and mefenamic acid. Batch adsorption of both 
non-steroidal anti-inflammatory drugs by activated charcoal  and a composite micelle 
(otadecyltrimethylammonium (ODTMA)–clay (montmorillonite) was determined at 25 ˚C. The 
results revealed that both adsorption fit Langmuir isotherm with Qmax of 66.7 mg/g and 62.5 
mg/g for ibuprofen using activated carbon and clay-micelle complex, respectively, and with Qmax
of 90.9 mg/g and 100.0 mg/g for mefenamic acid using activated charcoal and clay-micelle 
complex, respectively. These results suggest that an integration of a clay-micelle column in 
wastewater treatment plant is highly promising and can lead to improvement of the removal 
efficiency of these drugs from wastewater
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1.1 Background
The consumption of water over the world is increasing, and the demand on water resources 
for household, commercial, industrial, and agricultural purposes are also in rise. This soaring 
in demand is due to a rapidly expanding population, industrial expansion, and the need to 
expand irrigated agriculture [1]. But this expanding in population offset by a decrease in 
fresh water resources and low water availability.
In the Middle East, in general, and in Palestine in particular, water resources are very 
limited, in the West Bank Israel controls disproportionate amount of water systems it shares 
with Palestine, it effectively controls 100% of the Jordan river basin and more than 80% of 
underground water resources, and as a result a serious shortage problem exists [2-4].
This situation would be aggravated in the future, since the water balance gap between the 
available water supplies and water demands, as a result of population growth, rapid 
urbanization and industrial associated with living strands improvement, will increase. This 
gap along with contamination of ground water and surface water by industrial effluents, and 
agricultural chemicals, will cause serious shortage of fresh water and high production of 
wastewater [1, 4-7].
The water consumption in Palestine which is considered as a semiarid country is divided 
among three principle sectors: (1) Agricultural sector consumes around 70% , and represent 
the largest consumer of water in Palestine, (2) Domestic sector which consumes about 27% 
of water consumption, (3) and finally industrial sector which uses only 3% of the total water 
used, (Figure 1-1) [5].
3    Figure 1-1: Water consumption in Palestine [5]
The ground water is the main source of fresh water in Palestine, the sources of fresh water in 
Palestine suffer from Israeli confiscation and control [8] . 
This situation requires to preserving all water supplies that currently exist, and control water 
usage and use it efficiently, minimize water pollution and water contamination by reducing
wastewater flows and also finding solutions for disposal, treatment and recycling of 
wastewater.
Reducing wastewater flows will contribute in decreasing adverse effects, because untreated 
or partially treated wastewater causes health and environmental hazard [9-10].
1.2 Wastewater management in Palestine   
The major sources of wastewater types can be classified as municipal, industrial and 
agricultural [72]. Municipal water consists of wastewater from homes and commercial 
establishments. The main goal of treating wastewater is to reduce its adverse content of 
suspended solids, oxygen-demanding materials, dissolved inorganic compounds, and 
harmful bacteria [11].
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4In Palestine during the occupation period (1967-1994), wastewater sector was neglected, as a 
result the status of wastewater sector characterized by poor sanitation, insufficient treatment, 
and unsafe disposal of untreated or partially treated wastewater into the environment. 
Approximately 60% of the houses in urban communities are connected to sewage system,
The connection rate in the major cities varies between 50% in Qalqiliya to 85% in
Bethlehem. Some large towns and cities have no system at all, and wastewater is discharged 
into septic tanks and/or emptied into valleys (wadis), therefore the situation of sewage 
system is extremely critical. In the villages no sewage networks exist, and wastewater is 
collected in cesspits or septic tanks, most of Israeli settlements in the West Bank discharge 
the wastewater in wadis without any treatment and only 1% of collected municipal
wastewater is properly treated, Today, most of the municipalities are in charge of supplying 
water and collecting wastewater, but these institutions suffer from limited financial and 
managerial capacities to perform their functions. [12-13].
The existing urban sewage collection and treatment facilities are constrained by limited 
capacity, poor maintenance, process malfunction and lack of experienced or poor trained 
staff [14-15]. Generally water reuse application can serve many purposes, such as landscape 
irrigation which is considered as the largest field in using reclaimed wastewater [1, 16-17], 
and to achieve a sustainable and effective application of water reuse, the treatment system 
process must be able to isolate industrial toxins, pathogens carbon, and nutrient to prevent
adverse impacts on public health that may result from untreated wastewater reuse [18].
The treated or partially treated wastewater that is discharged in many areas in the West Bank
is presently used for irrigation purposes, but in a small-scale projects due to lack of
experience that is required for safe usage [18]. The reuse of treated wastewater must be 
combined with strategies, to prevent health and environment adverse impacts from 
pathogens, heavy metals, pesticides, and pharmaceuticals. Therefore, the Palestinian 
National Authority (PNA) is acting in the field of water and wastewater management in 
terms of legislation, policies, and strategies, design and implementation of projects, as well 
as approving environmental laws that regulate the wastewater usage, also the Palestinian 
Water Authority (PWA) has established a guidelines extracted from rules issued by the 
World Health Organization (WHO) to ensure protection of public health and the 
5environment from discharge of untreated or inadequately treated wastewater effluents      
[19-21] .
The efficient sewage treatment systems are urgently needed in Palestine, because appropriate 
and sustainable sewage treatment technologies will help to preserve biodiversity and 
maintain healthy ecosystems [5]. Various methods for wastewater treatment have been used 
in Mediterranean countries, many are conventional such as activated sludge and biofilters
and others slightly less conventional, such as oxidation ditches, aerated lagoons and natural 
treatment system such as waste stabilization ponds [6]. In Palestine two types of treatment 
plant systems (conventional and less conventional) are used, stabilization ponds for small 
communities, tickling filter, oxidation ditches, and activated sludge for large scale 
community. (Table 1-1) lists the current status of existing and planned wastewater treatment 
in the West Bank [5] .
1.3 Thesis Outline
This thesis contains five chapters: Chapter 1 contains the introduction, Chapter 2 consists of 
literature review on pharmaceuticals present in wastewater, general information on 
wastewater and the technology used for its treatment, Chapter 3 reviews the materials and 
the methods used, as well as sampling and analysis, Chapter 4 the results and discussion, and 
Chapter 5 presents the conclusions and recommendations.
6Table 1-1 :Wastewater treatment plants (WWTP) in the West Bank                      
Name of WWTP Effluent 
Quantity m3/d
Type of Treatment
Al Aroub 12-15 -Duckweed-based pond system
- Small-scale biochemical system (JOHKASOU system)
- Aeration tank
Birzeit University 100 -Screen
- Equalization Tank
- Activated sludge
- Sand Filters
Deir-Samit- Hebron 40 - Sedimentation tank
- bio-filters
Ijnsnya- Nabuls 40 - Septic tank
- Anaerobic filter
Nabuls west salfit 25205 -Extended aeration
Kharas - Hebron 120 -Anaerobic stage
- Wetlands
- Sludge drying beds
- Effluent storage tank
Sarha- Nabuls 40 - Septic tank
- Constructed wetland
Al-Bireh 3200 - Screening
- Aeration tanks
- disinfection by UV radiation
Jenin 1500 - Aerated lagoon
Ramallah 1370 - Two aerated lagoons
Tulkarem 6742 - Stabilization ponds
Tafuh 1370 -Anaerobic rock filtration
Abu-Dees 2740 -Oxidation ditch
Halhul 2740 -Aerated pond system
Jarico 3290 -------------
Biddya 3000 -------------
Al-Ram 9000 -Aerobic sludge
-Stabilization 
-Activated sludge
7Chapter Two
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                                                 Literature Review
2.1 Wastewater: Definition and Characteristics   
In general wastewater can be defined as any water that has been used, and affected in quality 
by anthropogenic influence. The more specific definition of wastewater is a combination of 
water carried wastes removed from residence, institution, commercial, industrial 
establishments, and ground water [23] .Wastewater is about 99% water by weight referred as 
influent, and the remaining one percent includes suspending and dissolved organic 
substances and inorganic , as well as microorganisms [26], but this ratio may varies 
according to the activity that wastewater resulted from, but the constituents ratio is not less 
than 95% water, as water is often added during the flushing to carry the waste down a drain 
[23] .
The wastewater sources can be divided into two types, domestic wastewater, or “sewage” 
and this type resulted from homes, commercial places, and farms [27]. Domestic wastewater 
can also be divided into two elements, black water which originates from toilets and kitchens 
and is highly contaminated and grey water which originates from baths, showers, wash 
basins and washing machine and is generally less contaminated. Grey water makes up 40% -
60% of the total domestic wastewater volume [28]. Industrial/commercial wastewater is flow 
generated and discharged from manufacturing and commercial activities, a combination of 
domestic and industrial wastewater constituents is known as mixed wastewater [29]. The 
principal parameters for which wastewater is prescribed are the physical, chemical, and 
biological. The physical parameters include total solid contents which consist of total 
suspended solid (TSS) and total dissolved solids (TDS), particle size distribution, turbidity, 
temperature, conductivity, transmittance, density, color and odor. The chemical parameters 
include biochemical oxygen demand (BOD), chemical oxygen demand (COD) and all of 
these parameters considered organic chemical parameters, and other parameters like 
hardness, pH, salinity, ions and metals consider inorganic chemical parameters. Then the  
biological parameters are coliform, fecal coliforms, viruses [29-31]. 
92.2 Wastewater composition and characteristices 
Wastewater contains the following broad grouping of constituents:
1- Organic matter such as feces, hair, food, vomit, paper fibers, plant material, urea.
2- Nutrients (Nitrogen, phosphorus and potassium).
3- Inorganic matter (dissolved minerals).
4- Toxic chemicals such as pharmaceuticals drugs and personal care products.
5- Pathogens.
This composition in fact may differ from community to community, it depends on the 
source. For example the composition of wastewater coming from residential communities is 
not the same in areas having industrial units, the time also play a vital role in wastewater 
composition, because the largest amount of water entering municipal wastewater system 
during the diurnal interval and holidays, other factors such as size of community may also 
affect the wastewater composition [23-24].
2.3 Treatment objectives 
The overall objectives of wastewater treatment are associated with removal of pollutants, and 
protection and preservation of water resources. Of specific concern is protection of human 
health, by the destruction of pathogenic organisms present in wastewater prior to treated 
effluent being discharged to receiving waters bodies.    
2.4 Wastewater treatment process 
Treatment facilities incorporate numerous processes, which in combination achieve the 
desired water quality objectives. These processes involve the separation, removal and 
disposal of pollutants present in the wastewater.
The treatment of wastewater is accomplished by four basic methods or techniques; physical, 
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mechanical, biological and chemical. The physical method of treatment is unit operations 
used in wastewater treatment include; flow-metering, screening, mixing, sedimentation, 
accelerating gravity settling, floatation, filtration gas transfer and volatilization. Mechanical 
treatment methods involve the use of machines; Chemical treatment methods include many 
processes such as chemical precipitation, adsorption, disinfection, and dechlorination. The
biological method which play a vital role in the removal of pollutants which cannot be 
effectively achieved by other means like bacteria and microorganisms [11, 29].
Wastewater treatment usually consists of four stages: preliminary, primary, secondary, and 
tertiary. But the primary and secondary stages are considered the major steps, and the tertiary 
stage is required to achieve complete removal for pollutants which have not been removed 
by secondary treatment [26].
2.4.1 Preliminary treatment  
The influent that flows to treatment plant contains pieces and wood, rags, plastic and other 
debris in addition to sand, eggshells and other coarse inorganic materials, as well as organic 
matter from household, industrial, commercial and institutional water use, all these 
components are removed through combination of screening and settling [29-30, 32].       
2.4.2 Primary treatment 
In primary treatment, the objectives are to physically remove, large debris, grit and sands 
from wastewater by screening, settling, or floating [26]. During primary treatment 
wastewater flows into and through large settling tanks or clarifiers where the flow velocity is 
reduced. Here initial separation occurs, with 40% to 50% of the heavier settle able solids 
forming primary sludge on the bottom of the settling tanks, and lighter materials float to the 
tanks surface [29].
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2.4.3 Secondary treatment 
The secondary treatment is designed for removal of biodegradable dissolved and colloidal 
organics and suspended solids that have escaped the primary treatment by utilizing biological 
treatment process. In secondary treatment unit, three types of technologies can be applied to 
break down organic material with agitation and aeration. There are: activated sludge process, 
trickling filters, and lagoon system [30, 32].
Activated sludge process removes the dissolves organic material and converts colloidal 
matter to a biological sludge which rapidly settles. The activated sludge process uses a 
variety of mechanisms to utilize dissolved oxygen to promote the growth of biological floc 
that substantially breaks down and removes organic material, then allows these solids floc to 
settle out [29, 33-34].  
2.4.4 Tertiary treatment     
Any addition processing after secondary treatment is called tertiary treatment which is 
physical-chemical processes applied to remove more suspended solids, organic matter, 
nitrogen, phosphorous, heavy metals and bacteria. These process include, ozonation, photo-
catalytic degradation of recalcitrant compounds (UV/TiO2, and adsorption) [31, 34-36].
Tertiary treatment may also involve physical-chemical separation techniques such as carbon 
adsorption, flocculation/precipitation, membranes for advanced filtration, ion exchange, 
dechlorination and reverse osmosis [35].
2.5 Membrane filtration 
Membrane filtration technology is a separation process, in which a semi-permeable 
membrane acts as a filter that allows water flow through, while removing suspended solids 
and other substances [37]. Membrane technology has been used for a tertiary wastewater 
treatment process after secondary biological wastewater treatment as an advanced 
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wastewater treatment stage. Application of membrane technology to wastewater treatment 
has expanded due to increasingly stringent legislation and continuing advancement of 
membrane technology [38]. The semi-permeable membranes which acts as a filter or barriers 
used to separate and remove constituents from wastewater ranging from large visible 
particles, to molecular and ionic chemical species including bacteria, viruses, and other 
pathogenic microorganisms [30, 39].
In membrane separation process, the feed water is separated into stream that can pass 
through the membrane known as permeate, and a fraction of feed that cannot pass through 
the membrane known as retentate or concentrate [40]. The removal of suspended or colloidal 
particles based on the size of membrane pores relative to that of the particulate matter, in the 
applications that require the removal of dissolved contaminants, the molecular weight cutoffs 
(MWCO) is considered the main criteria for effective separation, because it specifies the 
maximum molecular weight of solute to be rejected, the removal process will be in range of 
100 to 500 Daltons [37], other parameters such as the kind of driving force (pressure, 
chemical structure and composition of membrane, geometry of construction , and type of 
feed flow) play a vital role in the membrane filtration process [39].
2.5.1 Membrane modules
There are four main types of membrane modules: 1) plate-and 2) frame, 3) tubular spiral 
wound, and 4) hollow fiber [41]. Hollow fiber and spiral wound modules constructions 
involves sealing the membrane material into an assembly, these types of modules are 
designed for long-term use (3-5 years ), these modules are used in drinking water treatment 
and also wastewater treatment [30, 42]. Hollow fiber and spiral wound are made from 
organic material (synthetic polymers i.e. polyamide,and polysulphone). Hollow fibers is 
narrow tube made of non-cellulosic polymer, in this type a bundles of individual fibers are 
sealed into a hydraulically housing as shown in (Figure 2-1A), the fiber usually have a small 
diameter, around 100 µID and ~ 200 µmod.
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In hollow fiber the feed flows into the module, the permeate flow into or out of the hollow 
fiber and is collected, while retentate exits the module for further treatment [43-44]. Spiral 
wound is one of the most compact and inexpensive membrane, in this type two flat sheet 
membranes are placed together with their active sides facing away from each other. Each flat 
sheet membrane has one active side through which the smaller molecules permeate through, 
a feed spacer which is a mesh composed of generally parallel elongated filaments positioned 
parallel to the flow direction of the feed stream and wherein the elongated filaments are 
connected by shorter bridge filaments which are placed between the two flat sheet 
membranes, the two flat sheet membranes with feed spacer separating them are rolled around 
perforated tube which called collection tube (Figure 2-1B).      
  Figure 2-1 : Hollow fiber (A) and spiral wound (B) modules         
Membrane filtration can basically be divided into four main technologies based on the 
driving force used for filtration: Microfiltration (MF), ultrafiltration (UF), nanofiltration 
(NF), and reverse osmosis (RO). Hollow fiber and spiral wound are used for microfiltration 
(MF), ultrafiltration and also reverse osmosis (RO) [45]. The driving force can be external 
pressure, electrical potential gradient, concentration gradient, the most commonly used 
membrane system in drinking water and wastewater treatment are pressure-driven 
membrane. Microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), and reverse 
osmosis (RO) use the pressure-driven force and are classified according to their pore size, 
(Table 2-1) shows the separation characteristic for various pressures-driven membrane 
process [39, 46].
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Table 2-1 : Comparison of pressure-driven systems
Parameters Membrane system
Low- pressure membrane High- pressure membrane
Microfiltration (MF) Ultrafiltration (UF) Nanofiltration (NF) Reverse Osmosis (RO)
Product particle 
size (µm)
0.08 to 2.0 0.005 to 0.2 0.001 to 0.01 0.0001 to 0.001
Retained 
compounds
Very small suspended 
particles, some 
colloids, most bacteria
Organic compounds > 
1000 Da, pyrogens, 
viruses, bacteria, 
colloids
Organic compounds > 
200 Da, some 
dissolved solids (i.e. 
multivalent ions)
Ions, Organic 
compounds >100 MW
Operating 
pressure, psi
1 to 15 30 to 100 80 to 125 ≥ 1,000
2.5.2 Microfiltration (MF) and ultrafiltration (UF)
Microfiltration (MF) and ultrafiltration (UF) are filtration processes, that operate on a 
physical sieving separation process [47], in terms of pore size, MF has the largest pore size 
(0.1- 3.0 microns), but UF pore sizes range from 0.01- 0.1 microns; for that MF is typically 
used for turbidity reduction, removal of suspended solids, giardia and cryptosporidium. On 
the other hand, UF membranes which have smaller pore size are used to remove some 
viruses, color, odor, and some colloidal natural organic matter [48]. In terms of driven force, 
both processes (MF and UF) require low trans-membrane pressure (1 -30 psi) to (operate 
LPMS), and both are used as pretreatment to desalination technologies such as (RO), (NF), 
and electro-dialysis [48].
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  2.5.3 Nanofiltration (NF) and Reverse osmosis (RO)
Nanofiltration is a medium to high-driven membrane filtration process (150 – 1000 Kpa), 
and has a pore size around 0.001 micron. Nanofiltration removes most organic molecules, 
nearly all viruses, most of the natural organic matter and some salts, where large ionic 
species, including divalent and multivalent ions, and more complex molecules are highly 
retained [30], while allows the diffusion of certain ionic solutes, such as sodium and chloride 
and monovalent ions in general. In (RO) a high-driven pressure against a semi-permeable 
membrane is required (more than 1000 Kpa), due to the great osmotic difference between the 
solutions on each side of membrane, which is greater than nanofiltration case. In terms of 
pore size RO filters have pore size around 0.0001 micron, the molecular weight cutoff
(MWCO) levels is less than 100D for RO membranes, and between 200 and 1000 D for NF 
membranes [49-50]. 
Osmosis occurs when a semi-permeable membrane separates two salts solutions of different 
concentrations, the water will migrate from dilute solution to a concentrated solution, and 
this will create what is called “osmotic pressure” (Figure 2-2). In RO membranes force is 
exercised against the osmotic pressure to make the water to move from the more 
concentrated solution to the much diluted one, this will increase the volume of water with 
lower concentration of dissolved solid [30, 45], (Figure 2-2)
Figure 2-2 : Osmosis (A), osmotic pressure (B), and reverse osmosis (c)
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2.6 Occurrence of Pharmaceuticals and personal care products (PPCPs) in      
wastewater
At present, there is an increasing concern on the presence of pharmaceutical compounds in 
the environment, the occurrence of drug compounds and their metabolites, and also personal 
care products (PCPs) in our surface and underground water became important issue, due to 
their potential risk to the health and aquatic environment. Thousands of tons of 
pharmaceuticals are used yearly with different purposes, such as prevention, diagnosis, care, 
and mitigation of diseases or improve the state of health, the same quantity or more 
consumed from PCPs which include analgesics, fragrances, sun screen shampoos and 
cosmetics. All these pharmaceuticals and PCPs can end up in the aquatic environment. 
Where the discharge of pharmaceuticals and PCPs from production facilities, hospitals and 
private household effluent, as well as improper disposal of unused drugs pose a burden on 
the environment [51-53]. The fate of these pharmaceuticals and PCPs will be in the 
wastewater treatment plants (WWTPs), where the conventional wastewater treatment in 
WWTPs are based on primary, secondary and tertiary in some cases, but these conventional 
treatments are not specifically designed to remove pharmaceuticals [51], so effluents from 
wastewater treatment plants (WWTPs) can be considered to be one of the most important 
sources of pharmaceuticals in aquatic environment, since these compounds are not fully 
eliminated during the conventional treatment process, and they are only partially eliminated 
[54].
2.6.1 Analytical methods
A number of studies indicated the presence of pharmaceuticals and (PCPs) traces in the 
aquatic environmental at different concentrations. For example, a study carried out in 
Australia, Brazil, Canada, Croatia, England, Germany, Greece, Italy, and USA performed in 
2007 detected more than 80 pharmaceuticals and their corresponding metabolites in the 
aquatic environment at concentrations in the µgL-1 range or lower, another study performed 
in Spain reported the presence of 13 pharmaceuticals and personal care products (PPCPs) in 
municipal wastewater, eight compounds were detected in raw wastewater in the range (0.6 –
6.6 µgL-1) [55], another study demonstrated that 27 of 32 pharmaceutical substances and four 
of five metabolites were detected in European municipal wastewater treatment plant 
effluents at values of over 1 µgL-1. Generally, drug residue concentrations in receiving water 
fall in the low ngL-1 to low µgL-1 [61].  
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The presence of pharmaceuticals and personal care products (PPCPs) at trace levels         
(ngL-1) and in complex water matrices, such as wastewater and surface water, making their 
analysis difficult [56]. Currently, no standardized analytical methods are available for the 
analysis of pharmaceuticals and organic micropollutants in general in environmental waters, 
because these pharmaceuticals represent structurally diverse classes of compounds, and 
owing to the diversity of physic-chemical properties, so different analytical methods have 
been used for identification and quantification of these chemicals in water samples [57], the 
most common sample isolation and pre-concentration technique is solid phase extraction 
(SPE) [53], SPE also used for cleanup and extract of pharmaceuticals in water samples [58], 
variations of SPE include solid phase micro-extraction (SPME) [59]. 
2.6.2 Health effects
Even that pharmaceuticals residue and their metabolites are usually detectable in the 
environment at trace levels, the low concentration level (ngL-1 - µgL-1 ) can induce toxic 
effects, as in the cases of antibiotic and steroids that cause resistance in natural bacterial 
populations or endococine disruption effects [60]. Pharmaceutical compounds are designed 
to interact with receptors in humans and animals, but in aquatic environment the organisms 
exhibiting the same enzyme receptors as humans could experience similar pharmacodynamic 
effects. Another issue at the ecosystem level is that for continual exposure of organisms due 
to continuous discharge of sewage contaminants into receiving waters [61]. Although 
concentrations of many pharmaceuticals residues in potable drinking water are so low and do 
not pose high risks to human beings, the main concern is the chronic and/or synergistic 
effects of the “cocktail” of pharmaceuticals that human have released to water body [62-63] .
2.6.3 Method of treatment
The methods of treatment used for the removal of pharmaceuticals from the wastewater are 
the following: (a) biodegradation, (b) deconjugation, (c) partitioning, (d) removal during 
sludge treatment,and (e) photodegradation [64].
(a) Biodegradation: biological degradation can take place in wastewater by means of 
aerobic/anaerobic microbial degradation of the drug substance leading to reduction of parent 
compounds and/or their metabolites during wastewater treatment [64]. The microbes include 
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bacteria, yeasts, fungi, protozoa, and unicellular plants and rotifers, some of these organisms 
have the ability to degrade some of most hazards and recalcitrant chemicals and PPCPs [65].
(b) Deconjugation: pharmaceuticals compounds are often metabolized in the liver, and as a 
consequence gluconoride and sulfate conjugates of the parent drug are excreted, 
deconjugation in domestic wastewater and within sewage treatment plants (STPs), for 
organic compounds such as steroid hormones were occur due to the large amounts of β-
glucuridase enzyme present, gluconoride and sulfate conjugates of drug compounds will be 
degraded by the same process, the effect will be increase the excreted contribution of the 
active drugs to sewage and effluents.
(c) Partitioning: partitioning between the aqueous and organic biomass phase consider the 
key component in determining the ultimate concentration of organic pollutants. Compounds 
with high log Ko/w (lipophylic molecules) values are known to sorb to sludge, while 
substances with lower values are more likely to stay in the aquatic phase, depending on the 
individual compound, and substances sorbing to solids may also be remobilized if they are 
not strongly bound [64].
(d) Removal during sludge treatment: drugs may also be degraded by a biotic process 
(Hydrolysis) during sewage treatment process. Many pharmaceutical compounds are not 
thermally stable, and so might be expected to break down during processes such as 
compositing due to heat as well as chemical and biodegradation [64].
(e) Photodegradation: several pharmaceutical compounds have shown to degrade due to the 
action of sunlight, some pharmaceuticals compounds such as diclofenac which is 
analgesic/anti-inflammatory drug, has been shown to degrade in aquatic environment due to 
ultraviolet (UV) light [64].
Due to an incomplete elimination in (WWTPs) using the conventional treatment method, 
residues of pharmaceuticals are found in both wastewater and surface water [66], so the 
improvement of this situation require the application of advanced treatment techniques, such 
as membrane filtration technology, many studies reported as significant efficiency of 
nanofiltration and reverse osmosis [67], advanced oxidation processes [68], and activated 
carbon adsorption [64, 67].
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This thesis reports the efficiency of these advanced technology for removal of selected 
pharmaceuticals, ibuprofen and mefenamic acid, at the wastewater treatment plant at Al-
Quds University which includes ultrafiltration (hollow fiber and spiral wound).
This study reports the removal of two specific pharmaceuticals (ibuprofen, mefenamic acid) 
by ultrafiltration (hollow fiber and spiral wound), their adsorption by activated carbon and 
clay-micelle filters, and removal by reverse osmosis technology.
2.7 Thesis objectives   
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and mefenamic acid 
(Scheme 1) are extensively used as non-prescription drugs, with an annual consumption of 
several hundreds of tones in developed countries, as they are widely used for painful and
inflammatory conditions [22].
Figure 2-3 : Chemical structures for Ibuprofen (1), Mefenamic acid (2) and ODTMA (3).
The main goal of this research study was to investigate the performance of specifice
advanced treatment technologies which include integration between activated sludge process 
with ultra-filtration membranes (hollow fiber and spiral wound membranes), activated 
carbon adsorbent, micelle-clay filters, and reverse osmosis in terms of removal of ibuprofen 
and mefenamic acid. 
In this study the efficiency of the integrated membranes assembled in the wastewater 
treatment plant at Al-Quds University was tested for the removal of  ibuprofen and 
mefenamic acid from wastewater. A clay micelle complex octadecyltrimethylammonium 
(ODTMA, structure 3 in Scheme 1) and activated charcoal membranes were also included in 
the membranes plant system.
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Chapter Three
                                              Materials and methods
This chapter consists of three parts: part one describes the instruments used, part two 
documents the chemicals and reagents utilizes, the last part deals with the methods 
implemented.
3.1 Part one
3.1.1 Instrumentation 
3.1.1.1 High Performance Liquid Chromatography
High Performance Liquid Chromatography (HPLC-PDA) system consists of an alliance 
2695 HPLC (Waters: Milford,MA,USA), and a waters Micromass® Masslynx™ detector 
with Photo diode array (Waters 2996: Milford,MA,USA). Data acquisition and control were 
carried out using Empower ™ software (Waters: Milford,MA,USA). Analytes were 
separated on a 4.6 mm ×150 mm C18 XBridge® column (5 μm particle size) used in 
conjunction with a 4.6 mm × 20 μm XBridge™ C18 guard column. Microfilter was used 
with 0.45 μm (Acrodisc® GHP,Waters).
3.1.1.2 pH meter
pH meter model HM-30G: TOA electronics™ was used in this study to measure the pH 
value for the samples
3.1.1.3 Centrifuge and Shaker
Labofuge®200 Centrifuge was used, 230 V 50/60 Hz. CAT. No. 284811. Which is made in 
Germany. Some of pharmaceuticals solutions were shaken with an electronic shaker (Bigbill 
shaker, Model No.: M49120-26, 220-240 V 50\60 Hz.) at 250 rpm.
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3.1.1.4 Description of Wastewater Treatment Plant (WWTP)
The wastewater treatment plant (WWTP) at Al-Quds University collects a mixture of black, 
gray, and storm water. The treatment plant consists of a primary treatment (two stage 
primary settling basin), and a secondary (activated sludge with a hydraulic retention time of 
16-20 hours, coagulation and chlorination) treatment. Then, the secondary effluent is 
introduced to the sand filter before entering the ultra filtration membrane (Hollow fiber and 
Spiral wound). After the ultra filtration process, the effluent is subjected to activated carbon 
column followed by a reverse osmosis (advanced treatment). The ultra filtration process is 
made of two small scale membrane treatment plants with a capacity of 12 m3 /day. The first 
UF unit is equipped with 2 x 4 inch pressure vessels with pressure resistance up to 150 psi. 
Each vessel holds two separation membranes (spiral wound with 20 kD cutoffs which is 
equivalent to 0.01 micron separation rate). The designed permeate capacity of the system is 
0.5-0.8 m3/h. This Membrane can remove bacteria, suspended solids, turbidity agents, oil, 
and emulsions. The second unit is equipped with two pressure vessels made from Vendor 
(AST technologies, model number 8000 WW 1000-2M) that houses the hollow fiber 
membranes with 100 kD cutoff (Vendor, AST technologies, Model no. 8000- WWOUT-IN-
8080). The two units are designed to deliver 1 .5m3/h. The reverse osmosis (RO) membranes 
are made from thin film polyamide which consists of 1 x 4 inch pressure vessel made from 
composite material with pressure resistance up to 400 psi. The vessel holds two 4 inches 
special separation membranes (manufactured in thin film polyamide with pH range 1-11 
models BW30-4040 by DOW Film Tec.). Membrane anti-scalent (Product NCS-106-FG, 
made of phosphate in water with active ingredient of phosphonic acid disodium salt) are 
continuously dosed to the RO feed at concentration of 4 ppm in order to prevent deposition 
of divalent ions. The system is designed to remove major ions and heavy metals. The 
designed RO permeate capacity of the system is 0.45- 0.5 m3/h.
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3.2 Part two
3.2.1 Chemicals and Reagents
Pure standards of ibuprofen (> 99%), mefenamic acid (> 99%) were obtained from local 
pharmaceutical company (Birzet pharmaceutical company). Acetonitrile, methanol HPLC 
grade, orthophosphoric acid, magnesium sulfate, Charcoal activated fine powder with 
particle size (≤ 60.0 micron), charcoal activated granules with particle size (≤ 700.0 
micron), and octadecyltrimethyl ammonium (ODTMA) complex were purchased from 
Sigma chemical company, C18 (1 g) cartridges 6cc single use for general laboratory use 
were purchased form Waters company (Milford, MA, USA)  
3.3 Part three
3.3.1 Methods (Ibuprofen and mefenamic acid) 
3.3.1.1 Calibration curves using the solid phase cartridge
The C18 cartridges were preconditioned by passing first 10 mL of water through the 
cartridge and then 10 mL of acetonitrile. The cartridges were then air dried. Several 
solutions of ibuprofen and mefenamic acid with different concentrations (1.0, 5.0, 10.0, 
20.0, 30.0, 40.0, and 50.0 ppm) were prepared. 10 mL of each of these solutions was 
passed through the cartridge. The adsorbed mefenamic acid or ibuprofen was eluted from 
the adsorbent of the cartridge using 10 mL of acetonitrile. Afterwards, 20 µl of the eluate 
was injected into the HPLC and analyzed using the HPLC conditions for ibuprofen as the 
following: C18 column, wavelength = 220 nm, Flow rate = 2.0 mL/min, mobile phase: 50 
% of 0.07 % phosphoric acid solution/ 50 % Acetonitrile, and the HPLC conditions for 
mefenamic acid as the following: C18 column, wavelength = 350 nm, flow rate = 1.0 
mL/min., mobile phase: 10 % water, 90 % acetonitrile, pH = 3.0.
and mefenamic acid. Peak areas vs. concentration of ibuprofen and mefenamic acid was 
then plotted, and correlation coefficient of the plots were recorded. 
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3.3.1.2 Stability study of ibuprofen and mefenamic acid
3.3.1.2.1 Stability study in purified water
For this study, a 50 ppm solution of ibuprofen (prepared by dissolving ibuprofen in 
distilled water adjusted to pH 8.0 by using 1N sodium hydroxide) was used. Samples at 
specific time intervals (0, 1, 2, 4, 5, 10, 15, 20, 25, 30 days) were taken, and analyzed by 
HPLC method from USP for ibuprofen. The concentration of ibuprofen at each time 
interval was calculated from calibration curve and compared to the original concentration 
(50 ppm), and then the percentage of ibuprofen degraded was calculated. The same 
procedure was applied for mefenamic; HPLC method for mefenamic acid from USP was 
used. 
3.3.1.2.2 Stability study in the presence of sludge
The same procedure described in section (3.3.1.2.1) was applied for studying the 
stability of ibuprofen and mefenamic acid in the presence of sludge but water was 
replaced with a suspended sludge in wastewater from the plant. In this experiment
aeration was performed by pumping oxygen bubbles using electrical pump through tube 
placed at the bottom of trial flask to maintain the bacterial growth within the sample. 
3.3.1.3 Micelle-clay complex preparation
The micelle–clay complex was prepared by stirring 12mM of ODTMA with 10g/L clay 
for 72h. Suspensions were centrifuged for 20 min at 15 000 g, supernatants were 
discarded, and the complex was lyophilized. 
3.3.1.4 Calibration curves
(a) Stock solution: Stock solution was prepared by dissolving ibuprofen and mefenamic 
acid standards in water that adjusted to pH 8.0 (because both ibuprofen and mefenamic acid 
are soluble at this pH) to a concentration of 1000 ppm for the use in (b).
(b) Calibration curves: The following diluted solutions were prepared from the stock 
solution of ibuprofen (1.0, 5.0, 10.0, 25.0, 50.0, 100, 200, 500 and 1000.0 ppm) were 
prepared. 20 µl of each solution was injected into the HPLC and the peaks for ibuprofen 
were recorded using the following HPLC conditions: C18 column, wavelength = 220 nm, 
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Flow rate = 2.0 mL/min, mobile phase: 50 % of 0.07 % phosphoric acid solution/ 50 % 
acetonitrile.
For mefenamic acid, the same procedure was followed but using the following HPLC 
conditions: C18 column, wavelength = 350 nm, flow rate = 1.0 mL/min., mobile phase: 
10 % water, 90 % acetonitrile, pH = 3.0.
Peak areas vs. concentration of ibuprofen and mefenamic acid (in ppm) was then plotted, 
and R2 of the plots are recorded.
3.3.1.5 Batch adsorption isotherms
Equilibrium relationships between adsorbents (clay micelle complex and activated
charcoal) and adsorbate (ibuprofen and mefenamic acid) are described by adsorption 
isotherms, by studying the percentage of adsorbate removal occurred by both adsorbents 
(clay micelle complex and activated charcoal) at different concentrations (50, 100, 200,
500 and 1000 ppm) prepared in distilled water with pH = 8.0 adjusted by using 1M 
sodium hydroxide. The following procedure was applied: 100 mL from each solution was 
transferred to 200 mL Erlenmeyer flask, 0.5 g of the clay micelle complex was then 
added to the flask. Then the flask was placed on the shaker machine for 180 minutes. 
Afterwards, each sample was centrifuged for 5 minutes at 2500 rpm, and filtered using 
0.45µm filter. Then 20µl of the filtered solution was injected into the HPLC and the peak 
areas of ibuprofen and mefenamic acid were recorded.
3.3.1.6 Efficiency of the wastewater treatment plant (WWTP) of Al-Quds 
University for removal of ibuprofen and mefenamic acid
The efficiency of different membranes (hollow fiber (HF-UF), spiral wound (SW-UF), 
activated carbon and reverse osmosis (RO) membranes) for the removal of ibuprofen 
from wastewater was studied by spiking ibuprofen in the storage tank of the wastewater 
treatment plant at a concentration of 40 ppm (by dissolving 25 g of ibuprofen in the 
storage tank containing 625 liters of activated sludge wastewater). Samples were taken 
from the following points of the WWTP: (1) storage tank (before running wastewater 
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treatment plant) (2), (3), and (4) feed-, brine- and product-points of the HF-UF
membrane, respectively (5) and (6) concentrated -, and permeated-UF point of the HF-
SW membrane, respectively (7) activated carbon point, and (8) reverse osmosis point. 
These sampling points are shown in (Figure 3-1). 
Figure 3-1: Flow diagram showing the process of wastewater treatment plant which consists of HF-
UF filters (hollow fiber) and SW-UF (spiral wound), activated carbon and RO filters. 
These samples were treated using SPE C18 cartridge as follows: 10 mL of sample was 
loaded into the C18 cartridge, and allowed to pass through the cartridge by effect of 
gravity. Ibuprofen adsorbed on the C18 cartridge was then eluted using 10 mL of 
acetonitrile. 20 µl of the eluted solution was injected into the HPLC, and analyzed using 
the HPLC conditions for ibuprofen method of analysis. The concentration of ibuprofen in 
each sample was calculated using the calibration curve for ibuprofen using SPE cartridge 
(see section 3.3.1.1). The same procedure was applied to study the efficiency of the 
WWTP for removal of mefenamic acid where 40 ppm of mefenamic acid was spiked into 
the storage tank (by dissolving 25 g mefenamic acid in the storage tank containing 625
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liters of activated sludge wastewater). Sampling procedure and treatment of the samples 
by SPE cartridges was followed as described for ibuprofen. The procedure for calculation 
of the concentration of mefenamic acid in samples was also followed as described for 
ibuprofen, but using the HPLC conditions and calibration curve for mefenamic acid.
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   Chapter Four
                                                 Results and discussion
4.1 Ibuprofen
4.1.1 Introduction
Ibuprofen is derived from propionic acid which is produced by the hydrocarboxylation 
of ethylene using nickel carbonyl as the catalyst: 
H2C=CH2 + H2O + CO → CH3CH2CO2H
Ibuprofen is a stable white crystalline powder and is only very slightly soluble in water. 
Less than 1 mg of ibuprofen dissolves in 1 mL water (< 1 mg/ mL) [USP], it is soluble in 
organic solvents like acetonitrile and alcohols. Ibuprofen is a member of the class of 
agents commonly known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to 
relief the symptoms of a wide range of illnesses such as headaches, backache, period 
pain, dental pain, neuralgia, rheumatic pain, muscular pain, migraine, cold and flu 
symptoms and arthritis. Ibuprofen is OTC Over the Counter drug (OTC) and is consumed 
throughout Palestine as prescription and non-prescription drugs that reach the 
environment.
4.1.2 Calibration curve for ibuprofen using solid phase extraction cartridge (SPE)
The calibration curve was obtained by plotting peak area versus concentration (in 
ppm) and is displayed in (Figure 4-1) (seven data points) in the range 1.0 ppm – 50 
ppm) for ibuprofen. They showed excellent linearity with correlation coefficient (R2) of 
0.99. This indicates that the method used is quite reliable.
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    Figure 4-1: Calibration curve by using SPE for ibuprofen
4.1.3 Stability study of ibuprofen
4.1.3.1 Stability of ibuprofen in purified water
Stability studies of ibuprofen in purified water have been carried out where the
concentration of ibuprofen in purified water (pH 8.0) was 50 ppm and the temperature of 
the solution was kept at 25 C° for 30 days. Samples were taken at different time intervals 
(0, 1, 2, 4, 5, 10, 15, 20, 25, and 30 days).The results showed that ibuprofen was stable at 
these conditions and no degradation was detected. (Figures 4-2 and 4-3).
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Figure 4-2 : Chromatogram showing ibuprofen after 0 days in purified water
Figure 4-3 : Chromatogram showing ibuprofen after 30 days in purified water
4.1.3.2 Stability study in wastewater containing sludge
Stability studies of ibuprofen was also conducted (as in previous section 4.1.3.1) in 
wastewater containing sludge (pH 8.0) with total plate count (TPC) = 25 X107 cfu/100
mL at 25 C° for 30 days. The results revealed that ibuprofen was also stable in this 
media, and no degradation was observed. (Figures 4-4 and 4-5).
. 
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Figure 4-4: Chromatogram showing ibuprofen after 0 days in wastewater
Figure 4-5: Chromatogram showing ibuprofen after 30 days in wastewater
4.1.4 Calibration curve
The calibration curve was obtained by plotting peak area versus concentration of 
ibuprofen and is displayed in (Figure 4-6) (ten data points). The Figure shows excellent 
linearity in the range 1.0-1000.0 ppm with correlation coefficient (R2) of 0.999, this
indicates that the method used is linear.
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4.1.4.1 HPLC conditions for analysis of ibuprofen
C18 column, wavelength = 220 nm, Flow rate = 2.0 mL/min, mobile phase: 50% of 0.07 
%  phosphoric acid solution/50% acetonitrile.
Figure 4-6: Calibration curve for Ibuprofen (peak area vs. conc. of ibuprofen)
4.1.5 Adsorption studies of ibuprofen on a clay micelle complex (ODTMA) and 
activated charcoal
Adsorption mechanism depends on the physicochemical properties of the 
pharmaceutical and the aquifer media properties. Adsorption of ibuprofen onto a clay 
micelle complex and charcoal adsorbents was investigated and described in this 
section.
4.1.5.1 Adsorption of ibuprofen on the clay micelle complex (ODTMA)
A clay micelle complex (ODTMA) is prepared by mixing certain type of clay mineral 
(montmorillonite) with cationic surfactant. In this study octadecyltrimethylammonium 
(ODTMA), (Figure 4-7) with a critical micelle concentration (CMC) value of 0.3 mM
was employed for complex formation. A certain mass of clay was introduced into a 
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solution of ODTMA until reaching a concentration of 1 × 10-2 M then stirred for 24 
hours. The complex was filtered, dried and mixed with excess sand. This complex by 
virtue of its positive charge with hydrophobic region is capable of binding negatively 
charged organic molecules [70].
Figuer 4-7: Octa Decyl Trimethyl Ammonium (ODTMA)
4.1.5.1.1 Adsorption of ibuprofen on (ODTMA) at pH 4.0
The efficiency of octadecyltrimethylammonium (ODTMA) complex for removal of 
ibuprofen form a spiked sample was studied by preparing a solution of ibuprofen with
200 ppm concentration by dissolving ibuprofen in distilled water at pH = 4.0 adjusted by 
using 1M sodium hydroxide , 100 mL from this solution was then transferred to 200 mL  
Erlenmeyer flask, 0.5 g of the complex was added to the Erlenmeyer flask containing the 
sample of ibuprofen, then the Erlenmeyer flask was shacked for 180 minutes. Samples 
were taken according the following intervals.
Sample 
No.
1 2 3 4 5 6 7 8 9 10 11 12 13
Time 
(mintutes)
0 5 10 20 30 40 50 60 80 100 120 150 180
Each sample was centrifuged for 5 minutes, then it was filtered through 0.45 µ Millipore 
filter, 20 µl of each solution was injected into the HPLC and the peaks were recorded
using the same HPLC conditions used in the previous section (4.1.4.1), (Table 4-1) and 
(Figure 4-8) show incomplete removal of ibuprofen.
35
Table 4-1: Percentage removal of ibuprofen by clay micelle complex (ODTMA) at pH 4.0
No. sample Time (minutes) % Removal
1 0 0 
2 5 59.3
3 10 59.7
4 20 59.0
5 30 59.6
6 40 59.1
7 50 58.8
8 60 58.4
9 80 58.2
10 100 59.8
11 120 59.1
12 150 59.2
13 180 59.6
Figure 4-8: Adsorption of ibuprofen by clay micelle complex (ODTMA) at pH 4.0
The pKa of ibuprofen is 4.4 and the pH of the spiked samples is 4.0. Therefore at pH 4 a 
solution of ibuprofen will exist approximately 50% in the ionized and 50% in the non-
ionized forms. Results have shown that the percentage removal of ibuprofen in spiked 
samples at pH 4.0 was about 59.0%. This percentage of removal might be attributed to 
the interaction between the ionized forms of ibuprofen with the positively charged clay 
micelle complex. At pH 4, ibuprofen is 50% negatively charged and 50% uncharged, so 
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only the negative form of ibuprofen interacts with the positively charged complex 
indicating that the type of interaction between ibuprofen and the complex is electrostatic, 
while the hydrophobic interaction is negligible.
It is worth noting that the removal of ibuprofen is relatively fast: about 59% in 5 minutes,
however after this period of time the removal percentage remains constant up to three 
hours.
4.1.5.1.2 Adsorption of ibuprofen on (ODTMA) at pH 8.0
The percentage removal of ibuprofen by a clay micelle complex was also studied at pH 
8.0. The same procedure was applied as in section (4.1.5.1.1), by preparing a solution of 
ibuprofen at a concentration of 200 ppm in distilled water with pH = 8.0 adjusted by 
using 1M sodium hydroxide, where ibuprofen at pH 8.0 completely exists in the ionized 
form. Results have shown that ibuprofen is 90% removed at pH 8.0. This result (Table 4-
2) (Figure 4-9) demonstrated that the mode of interaction between ibuprofen and the clay 
micelle complex is mainly electrostatic, and hydrophobic interactions are scarily 
involved.
Table 4-2: Percentage removal of ibuprofen by clay micelle complex (ODTMA) at pH 8.0
No. sample Time (minutes) % Removal
1 0 0 
2 5 83.8
3 10 84.6
4 20 86.0
5 30 86.7
6 40 86.3
7 50 87.2
8 60 87.2
9 80 88.7
10 100 87.6
11 120 88.2
12 150 88.4
13 180 90.3
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Figure 4-9: Adsorption of ibuprofen by clay micelle complex (ODTMA) at pH 8.0
It is noting that about 84.0% of ibuprofen is eliminated in the first 5 minutes, and only 
about 6.5% of ibuprofen was removed during the remaining time (about three hours).
This indicates that the removal process that performed by clay micelle complex 
(ODTMA) is very fast.  
4.1.5.2 Adsorption of ibuprofen on the activated charcoal
The efficiency of activated charcoal for removal of ibuprofen form a spiked sample was 
studied by preparing 200 ppm concentration of ibuprofen in distilled water at pH = 8.0 
adjusted by using 1M sodium hydroxide , then 100 mL from this solution was transferred 
to 200 mL  Erlenmeyer flask, 0.5 g of the activated charcoal was added to an Erlenmeyer 
flask containing the sample of ibuprofen, then the Erlenmeyer flask was put on the shaker 
machine for 180 minutes. Samples were taken according the following intervals.
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No.
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Each sample was centrifuged for 5 minutes, then was filtered by 0.45 µ millipore filter, 
20 µl of each solution was injected into the HPLC and the peaks were recorded.  The 
same HPLC conditions used in the previous sections. (Table 4-3) and (Figure 4-10)
illustrate the removal of ibuprofen by activated charcoal.
Table 4-3: Percentage removal of ibuprofen by activated charcoal
No. sample Time (minutes) % Removal
1 0 0
2 5 49.6
3 10 52.3
4 20 69.6
5 30 82.3
6 40 89.3
7 50 91.9
7 60 94.5
8 80 96.1
9 100 96.7
10 120 97.8
11 150 98.5
12 180 99.1
Figure 4-10: Adsorption of ibuprofen by activated charcoal
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The results revealed that activated charcoal is effective for the removal of ibuprofen from 
spiked samples (200 ppm) at pH = 8.0. The removal was about 98% and was achieved 
after two hours.
The capacity of the clay micelle complex and activated charcoal towards adsorption of 
ibuprofen was quite comparable. The results showed that the adsorption of ibuprofen on 
the clay micelle complex is faster when compared to that on the activated charcoal (about 
84% of ibuprofen was removed in the first 5 minutes while only 49% of ibuprofen was 
removed by the activated charcoal. However, after three hours the adsorption capacity of 
the clay complex and the activated charcoal was about similar (90% for a clay complex 
and 99% for activated charcoal).   
4.1.5.3 Analysis of adsorption isotherms
Equilibrium relationships between adsorbents (clay micelle complex and charcoal) and 
adsorbate (i.e ibuprofen) are described by adsorption isotherms. The most common 
model for adsorption process is Langmuir adsorption isotherms which consider the most 
widely used modeling for equilibrium data and determination of the adsorption capacity 
[71]. It is a linear form and represented by the following equation:
       Ce/Qe = 1/ (K Qmax) + Ce/Qmax……………… Eq. (1)
Where: 
Ce: equilibrium concentration of ibuprofen (mg/L).
Qe: the equilibrium mass of the adsorbed ibuprofen per gram of complex (mg.g 
-1)
(mg.g -1).
K: Langmuir constant 
Qmax: maximum mass of Ibuprofen removed per gram of complex (mg.g 
-1)
For this study the adsorption of ibuprofen of five concentrations (50, 100, 200, 500, and 
1000 ppm) on the clay micelle complex and activated charcoal were studied, then Ce, and 
Qe were calculated as in (Tables 4-5 and 4-6). Ce/Qe vs. Ce was plotted for ibuprofen 
adsorbed onto both clay micelle complex and activated charcoal (Figure 4-11). 
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Figure 4-11: Langmuir isotherms for the removal of ibuprofen
The two parameters Qmax and K values for adsorption of ibuprofen on clay micelle 
complex and activated charcoal can be calculated from the slopes and y-intercepts of the 
equations obtained from the plots (Qmax = slope
-1, K = (y-intercept)-1(Qmax)
-1). (Table 4-4)
shows the values for Qmax and k for ibuprofen adsorbed on both clay micelle complex and 
activated charcoal. Qmax and K parameters for the removal of Ibuprofen by the clay 
micelle complex was calculated as follows:-
Slope = 1/ Qmax = 0.016; Qmax = 62.5 mg/g … … … … … … Eq. (2)
Intercept = (1/ K x Qmax) = 0.025; K = 0.64 … … … … … … Eq. (3)
The same procedure was applied for calculation of the Qmax and K for removal of 
ibuprofen by the activated charcoal, (Table 4-4)
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Table 4-4: Langmuir adsorption parameters (k and Qmax) of ibuprofen onto clay micelle complex and 
activated charcoal adsorbents.
Pharmaceutical Adsorbents Langmuir
K (L/mg) Qmax (mg/g) R²
Ibuprofen Clay micelle 
complex
0.64 ± 
0.03
62.5 ± 0.68 0.998
Charcoal 0.65 ±0.03 66.7 ± 0.35 0.999
* Results of K and Qmax are repeated as value ± SD; SD: standard deviation of three 
replicates  
Table 4-5: Concentrations in equilibrium obtained for adsorption of ibuprofen onto the adsorbent 
clay micelle complex
Conc. (initial) 
(mgL-1)
Mass 
(initial) 
(mg)
Conc. 
(final) 
(mgL-1)
(Ce)
Mass 
(final) 
(mg)
M initial -
M final
Qe= (M initial - M 
final) /0.5 g
Ce/Qe
48.8 ppm 4.88 0.56 ppm 0.056 4.824 9.648 0.06
103.8 ppm 10.38 1.8 ppm 0.18 10.2 20.4 0.09
208.6 ppm 20.86 20.2 ppm 2.02 18.84 37.68 0.54
519.0 ppm 51.9 180.3 ppm 18.03 33.87 67.74 2.66
988.6 ppm 98.86 686.6 ppm 68.66 28.62 60.4 11.36
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Table 4-6: Concentrations in equilibrium obtained for adsorption of ibuprofen onto the adsorbent 
activated charcoal 
Conc. (initial) (mgL-1) Mass 
(initial) 
(mg)
Conc. (final) 
(mgL-1)
(Ce)
Mass 
(final) 
(mg)
M initial 
- M final
Qe= (M initial - M 
final) /0.5 g
Ce/Qe
52.0 ppm 5.2 0.28 ppm 0.028 5.172 10.344 0.027
86.4 ppm 8.64 2.4 ppm 0.24 8.4 16.8 0.14
184.6 ppm 18.46 1.6 ppm 0.16 18.3 36.6 0.043
394.8 ppm 39.48 36.9 ppm 3.69 35.8 71.6 0.52
835.6 ppm 83.56 513.3 ppm 51.33 32.23 64.46 8.0
The results demonstrated that both adsorbents, clay micelle complex and activated 
charcoal, have the same efficiency for the removal of ibuprofen as both Qmax are 
comparable (62.5 mg of ibuprofen per gram of complex, and 66.7 mg of ibuprofen per 
gram of activated charcoal) , As shown in (Figure 4-6) the relationship between Ce/Qe
and Ce is linear for both the clay micelle complex and activated charcoal with R
2 greater 
than 0.99 which indicates that the adsorption of ibuprofen onto clay micelle and charcoal 
follows the Langmuir isotherm model.
4.1.6 Efficiency of the wastewater treatment plant (WWTP) at Al-Quds University 
for the removal of ibuprofen
The efficiency of the wastewater treatment plant (WWTP) at Al-Quds University for 
ibuprofen removal was studied. Result demonstrated that ibuprofen was 59.8% removed 
at hollow fiber stage (UF-HF), while about 94.7% of ibuprofen was removed at spiral 
wound (SW) stage, (Tables 4-7 and 4-8). At the activated carbon adsorbent point of the 
wastewater treatment plant, 98.8% of ibuprofen was removed. The results also indicated
that complete removal (99.9%) of ibuprofen was achieved after passing through the 
reverse osmosis membrane ,RO, (Figures (4-12,4-13,4-14 and 4-15)
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Figure 4-12: Chromatograms showing the initial concentration of ibuprofen and after running 
the HF-UF point (figure 3-1)
Figure 4-13: Chromatogram showing the concentration of ibuprofen before and after running 
the SW-UF point (Figure 3-1)
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Figure 4-14: Chromatogram showing the concentration of ibuprofen before and after running 
activated charcoal adsorbent point (Figure 3-1)
Figure 4-15: Chromatogram showing the concentration of ibuprofen after passing reverse 
osmosis (RO) membrane (Figure 3-1)
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Table 4-7: Removal of ibuprofen through the hollow fiber (UF-HF), spiral wound (UF-SW), activated 
carbon adsorbent and reverse osmosis from the wastewater treatment plant at Al-Quds university.     
No.
Sample location name Conc. of 
Ibuprofen 
(ppm)
First trial
Conc. of 
Ibuprofen 
(ppm)
Second trial
Conc. of 
Ibuprofen 
(ppm)
Third trial
1 Blank (before addition of ibuprofen) 0 0 0
2 The initial concentration of ibuprofen in 
storage tank (after addition of ibuprofen)
37.1 42.4 40.0
3 HF-UF Feed point 35.1 42.4 40.0
Brine point 35.7 41.9 40.1
Product point 9.7 15.3 23.4
4 HF-SW Concentrated UF   point 2.0 15.3 23.4
Permeated UF point 1.1 4.4 1.0
5 Activated carbon point 0.27 0.37 0.83
6 Reverse osmosis
  (RO)
Brine RO point 0.24 0.04 0.82
Permeated RO point 0.0 0.0 0.0
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Table 4-8: Accumulative % removal of ibuprofen.
Trial No. Hollow fiber (HF) Spiral wound (SW)   Activated carbon Reverse osmosis 
(RO)
1 73.9 % 97.1 % 99.3 % 99.8 %
2 63.9 % 89.6 % 99.1 % 100.0 %
3 41.5 %     97.5 % 97.9 % 99.9 %
Average 59.8 % 94.7 % 98.8 % 99.9 %
SD 16.6 4.5 0.76 0.1
These findings demonstrate that the WWTP at Al-Quds University is effective for a 
removal of ibuprofen. UF-HF and UF-SW are responsible for 60% and 95% removal 
while activated carbon and RO are responsible for 99% and 99, 9%, respectively. Hence, 
activated carbon and RO system are crucial components for a removal of ibuprofen so 
that environmental acceptable standard could be reached. 
4.2 Mefenamic acid
4.2.1 Introduction
Mefenamic acid is a non-steroidal anti
it is typically prescribed for oral administration
(swelling) and uterine contra
used in large quantities throughout Palestine
4.2.2 Calibration curve for 
(SPE)
The calibration curve was obtained by plotting peak area versus concentration 
ppm) and is displayed in (Figure 4
ppm for mefenamic acid. They showed excellent linearity with correlation coefficient 
(R2) of 0.99. This indicates that the method used is quite reliable.
Figure 4-16: Calibration curve by using SPE 
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4.2.3 Stability study of mefenamic acid
4.2.3.1 Stability of mefenamic acid in purified water
Stability studies of mefenamic acid in pure water have been carried out where the
concentration of mefenamic acid in pure water was 50 ppm and the temperature of the 
solution was kept at 25 C° for 30 days. Samples were taken at different time intervals (0,
1, 2, 4, 5, 10, 15, 20, 25, and 30 days).The kinetic results showed that mefenamic acid
was stable at these conditions and no degradation was detected as shown in (Figures 4-17
and 4-18).
Figure 4-17: Chromatogram showing mefenamic acid at 0 days in purified water
Figure 4-18: Chromatogram showing mefenamic acid at 30 days in purified water
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4.2.3.2 Stability study in wastewater containing sludge
Stability studies of mefenamic acid was also conducted (as in previous section 4.2.3.1) in 
wastewater containing sludge with total plate count (TPC) = 25 X107 cfu/100 mL at 25 
C° for 30 days. The results revealed that mefenamic acid was also stable in this media, 
and no degradation was observed as shown in (Figures 4-19 and 4-20).
Figure 4-19: Chromatogram showing mefenamic acid after 0 days in wastewater
Figure 4-20: Chromatogram showing mefenamic acid after 30 days in wastewater
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4.2.4 Calibration curve
The calibration curve was obtained by plotting peak area versus concentration and is 
displayed in (Figure 4-21) (eleven data points) for mefenamic acid, the figure showed 
excellent linearity in the range (0.8 -1000.0 ppm) with correlation coefficient (R2) of 1.0, 
this indicates that the method used is quite reliable.
Figure 4-21: Calibration curve for mefenamic acid
4.2.5 Adsorption studies of mefenamic acid on the clay micelle complex (ODTMA) 
and activated charcoal
Adsorption of mefenamic acid onto a clay micelle complex and charcoal adsorbents 
was investigated and described in this section as in ibuprofen.
4.2.5.1 Adsorption of mefenamic acid on the clay micelle complex (ODTMA)
The efficiency of octadecyltrimethylammonium (ODTMA) complex for a removal of 
mefenamic acid form a spiked sample was studied by preparing a solution of mefenamic 
acid with a concentration of 200 ppm, prepared by dissolving mefenamic acid in distilled 
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water at pH = 8.0 adjusted by using 1M sodium hydroxide ,then (as in ibuprofen) 100 mL
from this solution was transferred to 200 mL flask, 0.5 g of the complex was added to the 
Erlenmeyer flask containing the sample of mefenamic acid, then the flask was shaken for 
180 minutes. Samples were taken according the following intervals.
Sample 
No.
1 2 3 4 5 6 7 8 9 10 11 12 13
Time 
(mint.)
0 5 10 20 30 40 50 60 80 100 120 150 180
Each sample was centrifuged for 5 minutes, then was filtered by 0.45 µ millipore filter, 
20 µl of each solution was injected into the HPLC and the peaks were recorded using the 
same HPLC conditions for mefenamic acid used in the previous sections. (Table 4-9)
and (Figure 4-22) show about a complete removal of mefenamic acid by ODTMA 
complex.
Table 4-9: Percentage removal of mefenamic acid by clay micelle complex (ODTMA) 
No. sample Time (minutes) % Removal
1 0 Zero
2 5 96.9
3 10 97.2
4 20 98.5
5 30 98.9
6 40 98.1
7 50 98.1
8 60 97.5
9 80 98.1
10 100 98.0
11 120 97.9
12 180 97.3
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Figure 4-22: Adsorption of mefenamic acid by clay micelle complex (ODTMA) 
Results of this study revealed that only 5 minutes were enough for complete removal of 
mefenamic acid (97% removal). Similarly to ibuprofen, the results of mefenamic acid 
showed that electrostatic interaction between mefenamic acid and the clay micelle 
complex is the predominate mode of interaction rather than hydrophobic interaction.
Comparison of the removal of mefenamic acid and ibuprofen on the clay micelle
complex demonstrated that the removal of mefenamic acid is faster and more efficient 
than that of ibuprofen. 
4.2.5.2 Adsorption of mefenamic acid on activated charcoal
The capacity of activated charcoal for adsorption of mefenamic acid was studied, in the 
same manner for that of ibuprofen (section 4.1.5.2). The results indicated that activated 
charcoal is quite effective in removing mefenamic acid from spiked samples of (200 
ppm) (97.2% removal after 3 hours) (Table 4-10), (Figure 4-23).
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Table 4-10: Percentage removal of mefenamic acid by charcoal
No. sample Time (minutes) % Removal
1 0 Zero
2 5 28.4
3 10 37.2
4 20 51.9
5 30 60.9
6 40 60.9
7 50 74.2
7 60 78.9
8 80 85.3
9 100 90.0
10 120 93.0
11 150 96.3
12 180 97.2
Figure 4-23: Adsorption of mefenamic acid by activated charcoal
The combined results indicated that the capacity of a clay micelle complex and activated 
charcoal for an adsorption of mefenamic acid was quite comparable. In addition, the
results demonstrated that the adsorption of mefenamic acid on a clay micelle complex is 
very fast compared to that of mefenamic acid on activated charcoal, 96% of mefenamic 
acid was removed in the first 5 minutes by a clay complex vs. only 28% of mefenamic 
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acid was removed by activated charcoal. Furthermore, the adsorption of mefenamic acid 
on a clay micelle complex was faster than that of ibuprofen on the same clay (96% vs. 
84% in the first 5 minutes). It should be indicated that the adsorption mode of these two 
pharmaceuticals on activated charcoal is somewhat different. The percentage of the 
removal for mefenamic acid in the first 5 minutes by activated charcoal was only 28% 
whereas that of ibuprofen was 49.6%. However, after 3 hours, the adsorption capacity of 
the complex and activated charcoal was almost similar (97.3% when using clay micelle
complex and 97.2% when using activated charcoal).   
4.2.6 Analysis of adsorption isotherms
As for ibuprofen (section 4.1.5.3) the adsorption of mefenamic acid in different
concentrations (50, 100, 200, 500, and 1000 ppm) on clay micelle complex and activated 
charcoal was studied. The Ce, and Qe were calculated, then Ce/Qe was plotted against Ce
and the linear relationships obtained are illustrated in (Figure 4-24). As shown in (Figure 
4-23), the relationship between Ce/Qe and Ce is linear for both the clay micelle complex 
and activated charcoal with R2 greater than 0.99.
       Figure 4-24: Langmuir isotherms for the removal of mefenamic acid
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The two parameters Qmax and K values for adsorption of mefenamic acid on clay micelle 
complex and activated charcoal was calculated from the slops and y-intercepts of the 
equations obtained from the plots (Qmax = slop
-1, K = (y-intercept)-1(Qmax)
-1). (Table 4-11)
shows the values for Qmax and K for mefenamic acid adsorbed on both clay micelle
complex and activated charcoal. Qmax and K parameters for the removal of mefenamic 
acid by the clay micelle complex calculated as follows:-
Slope = 1/ Qmax = 0.010; Qmax = 100 mg/g … … … … … … Eq. (2)
Intercept = (1/ K x Qmax) = 0.095; K = 0.105 L/mg … … … … … … Eq. (3)
The same procedure was applied for calculation of the Qmax and K for removal of 
mefenamic acid by the activated charcoal, (Table 4-11)
Table 4-11: Langmuir adsorption parameters (K and Qmax) of Mefenamic acid onto clay micelle 
complex and activated charcoal adsorbents.
Pharmaceutical Adsorbents Langmuir
K (L/mg) Qmax (mg/g) R²
Mefenamic acid Clay micelle 
complex
0.105 ± 
0.004
100.0 ± 0.67 0.999
Charcoal 0.065 ± 
0.003
90.9 ± 0.74 0.99
* Results of K and Qmax are repeated as value ± SD; SD: standard deviation of three 
replicates  
Table 4-12: Concentrations in equilibrium obtained for adsorption of mefenamic acid onto the 
adsorbent clay micelle complex
Conc. (initial) 
(mgL-1)
Mass 
(initial) 
(mg)
Conc. 
(final) 
(mgL-1)
(Ce)
Mass 
(final) 
(mg)
M initial -
M final
Qe= (M initial - M 
final) /0.5 g
Ce/Qe
48.1 4.81 1.9 0.19 4.62 9.24 0.206
99.4 9.94 1.6 0.16 9.78 19.56 0.082
199.2 19.92 5.5 0.55 19.37 38.74 0.15
458.6 45.86 25.3 2.53 43.33 86.66 0.292
983 98.3 501 50.1 48.2 96.4 5.20
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Table 4-13: Concentrations in equilibrium obtained for adsorption of mefenamic acid onto the 
adsorbent activated charcoal
Conc. (initial) (mgL-1) Mass 
(initial) 
(mg)
Conc. 
(final) 
(mgL-1)
(Ce)
Mass 
(final) 
(mg)
M initial -
M final
Qe= (M initial - M 
final) /0.5 g
Ce/Qe
49.3 4.93 0.16 0.016 4.914 9.83 0.016
98.7 9.87 1.96 0.196 9.674 19.35 0.101
194.7 19.47 5.5 0.550 18.92 37.84 0.145
485.0 48.50 153.5 15.35 33.15 66.30 2.315
989.0 98.90 537.8 53.78 45.12 90.24 5.960
Qmax and k for adsorption of mefenamic acid and ibuprofen on the clay micelle complex 
and activated charcoal were calculated, and reported in (Table 4-14). The combined
results demonstrated that both adsorbents, clay micelle complex and activated charcoal, 
were quit efficient in the removal of mefenamic acid with both having close Qmax values
(100 mg of mefenamic per gram of complex vs. 91 mg of mefenamic acid per gram of 
activated charcoal). It is noteworthy here to compare the efficiency of both adsorbents for 
removal of ibuprofen and mefenamic acid by comparing Qmax values. It is clear from 
these values (Table 4-14) that both adsorbents have higher efficiency for removal of 
mefenamic acid compared to ibuprofen.
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Table  4-14 : Langmuir adsorption parameters (k and Qmax) of ibuprofen and mefenamic acid onto 
clay micelle complex and activated charcoal adsorbents
Adsorbent
Ibuprofen Mefenamic acid
k (L/mg) Qmax (mg/g) k (L/mg) Qmax (mg/g)
Clay micelle complex
0.64 ± 0.03 62.5 ± 0.68 0.105 ± 0.004 100.0 ± 0.67
Charcoal 0.65 ±0.03 66.7 ± 0.35 0.065 ± 0.003 90.9 ± 0.74
4.2.7 Efficiency of the WWTP at Al-Quds University for removal of mefenamic 
acid
The efficiency of the wastewater treatment plant at Al-Quds University for a removal of
mefenamic acid was studied in the same manner as described for ibuprofen, where 
mefenamic acid was spiked in a concentration of 40 ppm, and the experiment was 
repeated three times for the repeatability of the results. Samples were taken from the 
same locations as described in section (4.1.6). Results of samples were taken from 
hollow fiber points (UF-HF), demonstrated that mefenamic acid was approximately 
74.0% removed at this stage, while about 94.3% of mefenamic acid was removed after
passing the spiral wound (SW) stage (Tables 4-15 and 4-16). The sample taken after 
passing activated carbon adsorbent point showed that mefenamic acid is almost 
completely removed (98.8%). Finally analysis of the samples taken after passing the RO 
membrane stage which includes brine RO and permeated RO indicated that
approximately complete removal of mefenamic acid was achieved in this stage (99.5%),
(Figures 4-25,4-26,4-27 and 4-28).
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Figure 4-25: Chromatogram showing the initial concentration of mefenamic acid before and 
after running the HF-UF point (Figure 3-1)
Figure 4-26: Chromatogram showing the concentration of mefenamic acid before and after 
running the SW-UF point (Figure 3-1)
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Figure 4-27: Chromatogram showing the concentration of mefenamic acid before and after 
running activated charcoal adsorbent point (Figure 3-1)
Figure 4-28: Chromatogram showing the concentration of mefenamic acid after passing reverse 
osmosis (RO) membrane  (Figure 3-1)
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Table 4-15:  Removal of mefenamic acid by the hollow fiber (UF-HF), spiral wound (UF-SW), 
activated carbon adsorbent and reverse osmosis from the wastewater treatment plant.     
No.
Sample location name Conc. of 
Mefenamic acid  
(ppm)
First trial
Conc. of 
Mefenamic acid  
(ppm)
Second trial
Conc. of 
Mefenamic acid  
(ppm)
Third trial
1 Blank (before addition of Mefenamic acid) 0 0 0
2 The initial concentration of Mefenamic acid in 
storage tank (after addition of Mefenamic acid)
42.0 40.0 39.5
3 HF-UF Feed point 42.0 37.9 38.3
Brine point 18.0 38.0 36.0
Product point 1.1 11.3 18.4
4 HF-SW Concentrated UF   point 1.1 11.3 16.0
Permeated UF point 0.15 1.94 4.7
5 Activated carbon point 0.12 0.73 0.60
6 Reverse osmosis
  (RO)
Brine RO point 0.45 0.72 0.60
Permeated RO point 0.07 0.0 0.5
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Table 4-16: Accumulative % removal of mefenamic acid
Trial No. Hollow fiber (HF) Spiral wound (SW) Activated carbon Reverse osmosis 
(R.O)
1 97.8 % 99.6 % 99.7 % 99.8 %
2 71.8 % 95.2 % 98.2 % 100.0 %
3 53.4 %     88.1 % 98.5 % 98.7 %
Average 74.3 % 94.3 % 98.8 % 99.5 %
SD 22.3 5.8 0.79 0.7
It is interesting here to compare the efficiency of the WWTP at Al-Quds University for 
removal of ibuprofen and mefenamic acid. Referring to (Tables 4-8 and 4-15), it is clear 
that ultrafiltration points of the WWTP are not sufficient for complete removal of 
ibuprofen and mefenamic acid; however activated carbon and RO are crucial for almost 
complete removal of ibuprofen and mefenamic acid. Therefore, it is concluded that the 
RO membrane of the wastewater treatment plant is required for removal of ibuprofen and 
mefenamic acid to reach the acceptable environmental standards.        
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Chapter Five
       Conclusions and Recommendations
5.1 Summary and conclusions
In this study, two acidic pharmaceuticals, ibuprofen and mefenamic acid are found to be 
stable in wastewater (for 30 days).Therefore, it is necessary to find a method for removal 
of these pharmaceuticals from wastewater. Advanced wastewater treatment plant 
utilizing ultra filtration, activated carbon and RO showed that UF_HF and UF_SW are 
not efficient in removing both drugs to safe level. Whereas activated carbon and RO are 
efficient.  Adsorption studies on clay- micelle complex (ODTMA) and charcoal revealed 
that both adsorbents are  efficient for removal of ibuprofen and mefenamic acid at pH 8. 
The removal efficiency for ibuprofen are 90.3% and 99.1%, respectively, whereas the 
removal efficiency for  mefenamic acid are 97.3% and 97.2%, respectively. . 
These results indicate that integrating clay-micelle complex filters within the existing 
advanced membrane treatment system is very promising in improving removal efficiency 
and minimizing cost of treatment.
5.2 Recommendations
The most important recommendations for supporting the efficiency of advanced 
membrane technology towards the removal of pharmaceuticals in Palestine are:
 Associate projects for municipalities to provide wastewater treatment plants 
especially in industrial, agricultural, and hospital areas using advanced membrane 
technologies instead of traditional wastewater treatment pools. This is because it 
is efficient in terms of the removal of traces of pharmaceuticals.
 Educating the general public in the Palestinian society on how the 
pharmaceuticals should be disposed in order to prevent their entry into the 
64
environment. This can be done by raising the awareness towards the household 
disposal of unused and expired pharmaceuticals. 
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اﻟﻜﺮﺑﻮن  ﻣﺎدة ,دراﺳﺔ ﻣﺪى ﻛﻔﺎءة ﺗﻘﻨﯿﺔ اﻻﻏﺸﯿﺔ اﻟﻤﺘﻘﺪﻣﺔ ﻓﻲ ﻣﺤﻄﺔ ﻣﻌﺎﻟﺠﺔ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ
, اﻟﻤﺎز وﻣﺮﻛﺐ ﻣﯿﺴﻞ اﻟﺼﻠﺼﺎل اﻟﻤﻌﻘﺪ ﻓﻲ ازاﻟﺔ اﻟﻤﺮﻛﺒﺎت اﻟﺪواﺋﯿﺔ اﻟﺤﻤﻀﯿﺔ  اﻟﻤﻨﺸﻂ ذات اﻟﺴﻄﺢ
اﻻﯾﺒﻮﺑﺮﻓﯿﻦ وﺣﺎﻣﺾ اﻟﻤﯿﻔﯿﻨﺎﻣﯿﻚ ﻣﻦ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ
ﺳﺎﻣﺮ ﻣﺎھﺮ ﺧﻠﯿﻞ ﺧﻠﻒ: أﻋﺪاد
  .ﻓﺆاد اﻟﺮﯾﻤﺎوي .د،ﻗﺮﻣﺎنرﻓﯿﻖ .د.أ :إﺷﺮاف
 sgurd yrotammalfni itnA()ﻣﻦ اﻟﻤﻮاد اﻟﻤﺼﻨﻔﺔ ﻛﻤﻀﺪات اﻟﺘﮭﺎب  اﻟﺜﺒﺎﺗﯿﺔ ﻟﻤﺎدﺗﯿﻦ ﺻﯿﺪﻻﻧﯿﺘﯿﻦﺗﻢ دراﺳﺔ دراﺳﺔ 
ﻓﻲ اﻟﻤﯿﺎه اﻟﻨﻘﯿﺔ واﻟﻤﯿﺎه اﻟﻌﺎدﻣﺔ وﻟﻤﺪة ﺷﮭﺮ ﺣﯿﺚ اﻇﮭﺮت ھﺬة  وھﻤﺎ ﻣﺎدﺗﻲ اﻻﯾﺒﻮﺑﺮوﻓﯿﻦ وﺣﺎﻣﺾ اﻟﻤﯿﻔﯿﻨﺎﻣﯿﻚ( ,)sDIASN(
ﻟﻤﺘﻌﺪدة ﻓﻲ ازاﻟﺔ ھﺎﺗﯿﯿﻦ ﻓﺘﻢ دراﺳﺔ ﻣﺪى ﻛﻔﺎءة ﺗﻜﻨﻮﻟﻮﺟﯿﺎ اﻟﻔﺼﻞ اﻟﺤﺎﺟﺰي اﻟﻤﺘﻘﺪﻣﺔ ﺑﻤﺮاﺣﻠﮫ ا, اﻟﻤﻮاد ﺛﺒﺎﺗﯿﮫ وﻋﺪم ﺗﺤﻠﻞ
ﻓﻜﺎن اﻻداء ﻟﮭﺬه اﻟﺘﻘﻨﯿﺔ ﻛﻔﺎءة ﻋﺎﻟﯿﺔ ﻓﻲ ازاﻟﺔ ﺗﻠﻚ اﻟﻌﻘﺎﻗﯿﺮ وﺑﺸﻜﻞ ﻛﺎﻣﻞ ﺿﻤﻦ ﺣﺪود اﻟﻜﺸﻒ ﺑﺎﻟﻤﻨﮭﺞ اﻟﺘﺤﻠﯿﻠﻲ .اﻟﻤﺎدﺗﯿﻦ
ھﻲ اﻛﺜﺮ اﻟﻤﺮاﺣﻞ ﻓﻌﺎﻟﯿﺔ ﻓﻲ ازاﻟﺔ اﻟﺠﺰء اﻻﻛﺒﺮ ﻣﻦ ھﺬة اﻟﻌﻘﺎﻗﯿﺮ ﺑﻨﺴﺒﺔ وﺻﻠﺖ  اﻟﻜﺮﺑﻮن اﻟﻤﻨﺸﻂوﻛﺎﻧﺖ ﻣﺮﺣﻠﺔ اﻧﺒﻮب .اﻟﻤﺘﺒﻊ
وﻣﺮﻛﺐ  )tnebrosda nobrac detavitcA(اﻟﻤﺎز اﻟﻜﺮﺑﻮن اﻟﻤﻨﺸﻂ ذات اﻟﺴﻄﺢﻛﻤﺎ ﺗﻢ دراﺳﺔ ﻛﻔﺎءة ﻣﺎدﺗﻲ , %  8.89اﻟﻰ 
(hctaB)ﺗﺠﺮﯾﺒﯿﺔ ﻣﻌﯿﻨﺔ  ﻣﻦ ﺧﻼل دﻓﻌﺔ ﻓﻲ ازاﻟﺔ اﻟﻤﺮﻛﺒﺎت اﻟﺪواﺋﯿﺔ  )xelpmoc ellecim-yalC(ﻣﯿﺴﻞ اﻟﺼﻠﺼﺎل اﻟﻤﻌﻘﺪ
ﻛﻤﺎ ﺗﻢ دراﺳﺔ اﯾﺰوﺛﺮﻣﺎت اﻻﻣﺘﺰاز .ﺟﺪا ﻓﻲ ازاﻟﺔ ھﺬة اﻟﻌﻘﺎﻗﯿﺮﻣﺌﻮﯾﺔ ﺣﯿﺚ اﻇﮭﺮت اﻟﺪراﺳﺔ ﻓﻌﺎﻟﯿﺔ ﻛﺒﯿﺮة  52وﺑﺪرﺟﺔ ﺣﺮارة 
ﻛﻞ اﻻﯾﺰوﺛﺮﻣﺎت . وﻣﺮﻛﺐ ﻣﯿﺴﻞ اﻟﺼﻠﺼﺎل اﻟﻤﻌﻘﺪﻟﮭﺬة اﻟﻤﻮاد ﺑﺎﺳﺘﺨﺪام ﻛﻞ ﻣﻦ اﻟﻜﺮﺑﻮن اﻟﻤﻨﺸﻂ ( mrehtosi noitprosdA)
 7.66 (xamQ)ﺑﺤﺪ اﻣﺘﺼﺎص اﻗﺼﻰ  (mrehtosi riumgnaL)اﻟﺘﻲ ﺗﻢ دراﺳﺘﮭﺎ وﺟﺪ ﺑﺎﻧﮭﺎ ﺗﺘﻄﺎﺑﻖ ﻣﻊ اﯾﺰوﺛﺮم ﻻﻧﻜﻤﺎﯾﺮ 
ھﺬة اﻟﻨﺘﺎﺋﺞ ﺗﺸﯿﺮ ,وﺣﺎﻣﺾ اﻟﻤﯿﻔﯿﻨﺎﻣﯿﻚﻏﻢ ﻟﻤﺎدة /ﻣﻠﻐﻢ 0.001ﻏﻢ و /ﻣﻠﻐﻢ 9.09ﻏﻢ ﻟﻤﺎدة اﻻﯾﺒﻮﺑﺮﻓﯿﻦ و /ﻣﻠﻐﻢ 5.26ﻏﻢ و  /ﻣﻠﻐﻢ
وﯾﻤﻜﻦ ﯾﺒﺸﺮ ﺑﻨﺘﺎﺋﺞ واﻋﺪة   )xelpmoc ellecim-yalC(ﻣﯿﺴﻞ اﻟﺼﻠﺼﺎل اﻟﻤﻌﻘﺪﻌﻤﻮد ﻣﻦ ﻣﺎدة ﺑ ان ﺗﺤﺴﯿﻦ اداء ﻣﺤﻄﺔ اﻟﻤﻌﺎﻟﺠﺔ
  .ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ ﻣﻦھﺬه اﻷدوﯾﺔإزاﻟﺔةﺗﺤﺴﯿﻦ ﻛﻔﺎءأن ﯾﺆدي إﻟﻰ
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ﻋﻤﺎدة اﻟﺪرﺳﺎت اﻟﻌﻠﯿﺎ
ﺟﺎﻣﻌﺔ اﻟﻘﺪس   
  
ﻣﺎدة اﻟﻜﺮﺑﻮن  ،دراﺳﺔ ﻣﺪى ﻛﻔﺎءة ﺗﻘﻨﯿﺔ اﻻﻏﺸﯿﺔ اﻟﻤﺘﻘﺪﻣﺔ ﻓﻲ ﻣﺤﻄﺔ ﻣﻌﺎﻟﺠﺔ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ
 ،اﻟﻤﺎز وﻣﺮﻛﺐ ﻣﯿﺴﻞ اﻟﺼﻠﺼﺎل اﻟﻤﻌﻘﺪ ﻓﻲ ازاﻟﺔ اﻟﻤﺮﻛﺒﺎت اﻟﺪواﺋﯿﺔ اﻟﺤﻤﻀﯿﺔ  اﻟﻤﻨﺸﻂ ذات اﻟﺴﻄﺢ
ﻣﻦ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ اﻻﯾﺒﻮﺑﺮﻓﯿﻦ وﺣﺎﻣﺾ اﻟﻤﯿﻔﯿﻨﺎﻣﯿﻚ
اﻋﺪاد 
ﺳﺎﻣﺮ ﻣﺎھﺮ ﺧﻠﯿﻞ ﺧﻠﻒ
رﺳﺎﻟﺔ ﻣﺎﺟﺴﺘﯿﺮ
ﻓﻠﺴﻄﯿﻦ -اﻟﻘﺪس
ھﺠﺮي 3341/ م  2102
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ﻣﯿﺎه اﻟﺼﺮف دراﺳﺔ ﻣﺪى ﻛﻔﺎءة ﺗﻘﻨﯿﺔ اﻻﻏﺸﯿﺔ اﻟﻤﺘﻘﺪﻣﺔ ﻓﻲ ﻣﺤﻄﺔ ﻣﻌﺎﻟﺠﺔ 
اﻟﻤﺎز وﻣﺮﻛﺐ ﻣﯿﺴﻞ اﻟﺼﻠﺼﺎل  اﻟﺼﺤﻲ، ﻣﺎدة اﻟﻜﺮﺑﻮن اﻟﻤﻨﺸﻂ ذات اﻟﺴﻄﺢ
اﻟﻤﻌﻘﺪ ﻓﻲ ازاﻟﺔ اﻟﻤﺮﻛﺒﺎت اﻟﺪواﺋﯿﺔ اﻟﺤﻤﻀﯿﺔ، اﻻﯾﺒﻮﺑﺮﻓﯿﻦ وﺣﺎﻣﺾ 
اﻟﻤﯿﻔﯿﻨﺎﻣﯿﻚ ﻣﻦ ﻣﯿﺎه اﻟﺼﺮف اﻟﺼﺤﻲ
اﻋﺪاد 
ﺳﺎﻣﺮ ﻣﺎھﺮ ﺧﻠﯿﻞ ﺧﻠﻒ
، ﻓﻠﺴﻄﯿﻦﺟﺎﻣﻌﺔ اﻟﻘﺪس –ﻛﯿﻤﯿﺎء : ﺑﻜﺎﻟﻮرﯾﺲ
  ﻗﺮﻣﺎنرﻓﯿﻖ .د.أ : اﻟﻤﺸﺮف اﻟﺮﺋﯿﺲ                                
  ﻓﺆاد اﻟﺮﯾﻤﺎوي .د: اﻟﻤﺸﺎركاﻟﻤﺸﺮف                               
  
ﻗﺪﻣﺖ ھﺬه اﻻﻃﺮوﺣﺔ اﺳﺘﻜﻤﺎﻻ ﻟﻤﺘﻄﻠﺒﺎت درﺟﺔ اﻟﻤﺎﺟﺴﺘﯿﺮ ﻓﻲ اﻟﺘﻜﻨﻮﻟﻮﺟﯿﺎ اﻟﺘﻄﺒﯿﻘﯿﺔ 
  .ﻓﻠﺴﻄﯿﻦ -واﻟﺼﻨﺎﻋﯿﺔ ﻣﻦ ﻛﻠﯿﺔ اﻟﺪراﺳﺎت اﻟﻌﻠﯿﺎ ﻓﻲ ﺟﺎﻣﻌﺔ اﻟﻘﺪس
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